Lytics has recently been selected for the Bridge Market Check program which consists of a collaboration with Sahlgrenska Science Park and Business Sweden. The program has a focus on helping Swedish Med Tech companies enter the UK market, and the collaboration grants Lytics access to a broad network within the UK market, as well as in depth analyses and understandings of how the market functions.
Lytics sees the program as a natural next step which allows an establishment of our cutting edge technology on the UK market. Alongside this we always welcome a broadening of our existing network, as it allows us to interact with a larger range of like-minded people, which is what enables us to stay at the forefront of the technological developments within healthcare in the world today.
Lytics will always continue pushing for more effective healthcare, and greater international exposure as enabled by the program allows us to better the lives of more patients worldwide. We therefore look forward to the continued collaboration within the program and a greater establishment on the UK market.